Buchumschlag

TP53 ‐Mutated Acute Myeloid Leukemia: Unanswered Questions

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, Caterina Labanca, Giulio Caridà, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Noemi Puccio, Antonino Neri, Fortunato Morabito, Massimo Gentile
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Hematological Oncology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Therapeutic Strategies for Relapsed or Refractory B‐Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies
von: Antonella Bruzzese, et al.
Veröffentlicht: (2025)

Avatrombopag for the Treatment of Immune Thrombocytopenia
von: Caterina Labanca, et al.
Veröffentlicht: (2025)

Treatment‐Free Remission in Chronic Myeloid Leukemia: Revisiting the “W” Questions
von: Antonella Bruzzese, et al.
Veröffentlicht: (2025)

Therapy‐Related Acute Promyelocytic Leukemia: Case Series and Current Insights
von: Antonella Bruzzese, et al.
Veröffentlicht: (2024)

Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents
von: Ernesto Vigna, et al.
Veröffentlicht: (2025)

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment
von: Antonella Bruzzese, et al.
Veröffentlicht: (2026)

Real‐World Evaluation of Oral Decitabine/Cedazuridine in Elderly Patients With Acute Myeloid Leukemia
von: Ernesto Vigna, et al.
Veröffentlicht: (2025)

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies
von: Enrica Antonia Martino, et al.
Veröffentlicht: (2025)

Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives
von: Giulio Caridà, et al.
Veröffentlicht: (2025)

Real‐World Outcomes and Treatment Patterns in Patients With Acute Myeloid Leukemia and TP53 Gene Mutation or 17p Deletion
von: Rebecca Bystrom, et al.
Veröffentlicht: (2025)

Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
von: Saubia Fathima, et al.
Veröffentlicht: (2025)

Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications
von: Antonella Bruzzese, et al.
Veröffentlicht: (2024)

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
von: Mithun Vinod Shah, et al.
Veröffentlicht: (2025)

Vaccination in Multiple Myeloma: Challenges and Strategies
von: Enrica Antonia Martino, et al.
Veröffentlicht: (2025)

T‐Cell–Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions
von: Santino Caserta, et al.
Veröffentlicht: (2025)

Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?
von: Santino Caserta, et al.
Veröffentlicht: (2025)

Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs
von: Antonella Bruzzese, et al.
Veröffentlicht: (2026)

Mixed‐Phenotype Acute Leukemia With Mutated TP53 : Genetic Landscape, Therapeutic Response, and Outcomes
von: Wei J. Wang, et al.
Veröffentlicht: (2025)

Targeting the Menin– KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation
von: Antonella Bruzzese, et al.
Veröffentlicht: (2026)

First‐Line Treatment of IGHV ‐Unmutated Chronic Lymphocytic Leukemia: A Network Meta‐Analysis of Targeted and Chemoimmunotherapy Regimens
von: Santino Caserta, et al.
Veröffentlicht: (2026)

Acute Myeloid Leukemia With NPM1 Mutation Presenting With Rapidly Progressing Hypereosinophilia
von: S. Einarsdottir, et al.
Veröffentlicht: (2025)

Correction to “Isocitrate Dehydrogenase 2 Mutation Promotes Cytarabine Resistance in Acute Myeloid Leukemia by Warburg Effect”
Veröffentlicht: (2025)

Chemotherapy‐Sparing Strategies in Follicular Lymphoma: Emerging Targeted and Immune‐Based Approaches
von: Enrica Antonia Martino, et al.
Veröffentlicht: (2025)

Management of Primary Refractory Diffuse Large B‐Cell Lymphoma in Patients Unsuitable for CAR T‐Cell Therapy
von: Santino Caserta, et al.
Veröffentlicht: (2026)

Targeting Ikaros and Aiolos: Next‐Generation Cereblon E3 Ligase Modulators in MM
von: Maria Eugenia Alvaro, et al.
Veröffentlicht: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With a Germline DDX41 Mutation
von: Shuro Yoshida, et al.
Veröffentlicht: (2024)

Outcomes and Patterns of Relapse of NPM1 Mutated Acute Myeloid Leukemia Treated With Venetoclax Based Therapies
von: Wei‐Ying Jen, et al.
Veröffentlicht: (2025)

Acute Leukemias of Ambiguous Lineage With MDS‐Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS‐Associated Mutations: A Study From the Bone Marrow Pathology Group
von: Timothy J. Kirtek, et al.
Veröffentlicht: (2024)

Immunophenotypic, Genetic, and Clinical Features Associated With RUNX1 Mutation in Acute Leukemias and Chronic Myeloid Neoplasms
von: Yi Han Xia, et al.
Veröffentlicht: (2026)

Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or MRD ‐Positive NPM1 ‐Mutated Acute Myeloid Leukemia
von: Matteo Piccini, et al.
Veröffentlicht: (2026)

Real‐World Outcomes in NPM1 ‐Mutated Acute Myeloid Leukemia: The Impact of Measurable Residual Disease on Disease Relapse
von: Panagiotis Tsirigotis, et al.
Veröffentlicht: (2026)

TP53 Mutations Detected by NGS Are a Major Clinical Risk Factor for Stratifying Mantle Cell Lymphoma
von: Grégory Lazarian, et al.
Veröffentlicht: (2025)

Therapeutic Advances and Future of Therapy in Acute Myeloid Leukemia
von: Farhad Ravandi
Veröffentlicht: (2025)

BCR::ABL1‐Positive Acute Myeloid Leukemia
von: Alban Canali, et al.
Veröffentlicht: (2025)

From Time‐Limited Therapy to Treatment‐Free Observation: The Evolving Role of MRD in CLL Management
von: Enrica Antonia Martino, et al.
Veröffentlicht: (2026)

Acute Myeloid Leukemia (AML) With T‐Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML)
von: Anthony Crymes, et al.
Veröffentlicht: (2024)

Masking as Myelofibrosis: A Case of Tp53 Mutated Acute Erythroid Leukemia Presenting With Pancytopenia and Bone Pain
von: Karsten Parker, et al.
Veröffentlicht: (2025)

Identification of Potential Biomarkers and Pathways in Acute Myeloid Leukemia: Correlation Between the Calcineurin Signaling Pathway and Vascular Brittleness in Acute Myeloid Leukemia
von: Homood Alharbi, et al.
Veröffentlicht: (2024)

Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study
von: Hippolyte Guerineau, et al.
Veröffentlicht: (2024)

To Treat or Not to Treat: Navigating Early‐Stage CLL in the Era of Targeted Therapy
von: Enrica Antonia Martino, et al.
Veröffentlicht: (2026)